Affiliation:
1. Universidade Estadual de Campinas
2. CRCHUM: Centre Hospitalier de l'Universite de Montreal Centre de Recherche
Abstract
Abstract
Background
Medication adherence has a major impact on reducing mortality and healthcare costs related to the treatment of cardiovascular diseases and diabetes mellitus. The task of selecting the best PROM among the many available for this kind of patient is extremely important. This study aims to critically assess, compare and synthesize the quality of the measurement properties of patient-reported outcome measures to access medication adherence among patients with cardiovascular diseases and/or type 2 diabetes mellitus.
Methods
This review followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) and the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. The searches were performed in Web of Science, SCOPUS, PubMed, CINAHL, EMBASE, LILACS, PsycINFO, and ProQuest (gray literature).
Results
A total of 94 records including 24 different PROMs were included in the review. The records were published between 1986 and 2020, most of them were conducted in the United States, and in English language. The only PROM that reached the criteria of category A, e.g., that can be recommended for use and results obtained can be trusted is the ProMAS. The PROMs that shouldn’t be recommended for use (category “c”) are the MTA, LMAS-14, GMAS, MEDS, MNPS, MALMAS, ARMS-D, DOSE-Nonadherence, MGT, MARS-5, and A-14. The remaining PROMs, e.g., MMAS-8, SMAQ, DMAS-7, ARMS-12, MTA-OA, MTA-Insulin, ARMS-10, IADMAS, MAQ, MMAS-5, ARMS-7, and 5-item questionnaire were considered as having the potential to be recommended for use (category “b”).
Conclusion
ProMAS is the only PROM that could be considered trusted and recommended for use for patients with cardiovascular diseases and/or type 2 diabetes mellitus. However, another 12 PROMs has the potential to be recommended for use but need further studies to ensure their quality, according to COSMIN guideline for systematic reviews of PROMs.
Systematic review registration
PROSPERO CRD42019129109.
Publisher
Research Square Platform LLC
Reference119 articles.
1. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors;Polonsky WH;Patient Prefer Adherence,2016
2. Cardiovascular medication adherence among patients with cardiac disease: a systematic review;Al-Ganmi AH;J Adv Nurs,2016
3. World Health Organization. https://www.who.int/data/stories/leading-causes-of-death-and-disability-2000-2019-a-visual-summary (2020). Accessed 10 Jan 2022.
4. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (2020). Accessed 10 Jan 2022.
5. The Global Goals for Sustainable Development. https://www.globalgoals.org/3-good-health-and-well-being (2015). Accessed 10 Jan 2022.